Yes, Mounjaro (tirzepatide) lowers blood sugar in adults with type 2 diabetes. It stimulates insulin release when glucose is elevated. Thus, improving insulin sensitivity and reducing liver glucose production.

Approved by the MHRA in the UK, for adults with type 2 diabetes. Clinical trials have shown HbA1c reductions, though individual responses vary and results are not guaranteed.

What Is Mounjaro?

Mounjaro is the brand name for tirzepatide. It’s a once-weekly injectable medication approved by the MHRA for treating type 2 diabetes in adults. 

It’s the first dual GIP and GLP-1 receptor agonist. It works through two hormone pathways rather than the single pathway used by older injections like Ozempic or Victoza.

Available only on prescription in the UK. 

Mounjaro comes in pre-filled pens with doses ranging from 2.5 mg to 15mg. Treatment must be initiated and monitored by healthcare professionals experienced in diabetes management.

How Mounjaro Lowers Blood Sugar

Mounjaro mimics two natural gut hormones (GLP-1 and GIP) that regulate blood sugar:

GLP-1 Action

Stimulates insulin release only when blood glucose is elevated, preventing low blood sugar. It also suppresses glucagon, stopping your liver from releasing unnecessary glucose.

GIP Action

Improves how effectively your body’s tissues respond to insulin. It’s particularly important in type 2 diabetes, where insulin resistance is common.

Additional Effects

Slows stomach emptying, reducing post-meal glucose spikes by 30% to 50%. This also increases feelings of fullness, contributing to weight loss.

The glucose-dependent mechanism means Mounjaro only works when blood sugar is high. It significantly reduces hypoglycaemia risk compared to sulphonylureas or insulin.

How Effective Is Mounjaro at Reducing Blood Sugar?

Clinical trials show Mounjaro delivers powerful glycaemic control. It often outperforms established diabetes treatments.  

In the SURPASS trials, the 15mg dose achieved average reductions of 2.5%. Many patients reached HbA1c targets below 7%, and some even below 5.7%.

Clinical trials suggest Mounjaro may reduce HbA1c in some patients more than certain other diabetes treatments. Comparisons vary by study, dose, and patient population.

Mounjaro can lower fasting and post-meal glucose, but exact reductions vary by individual and should be monitored by a healthcare professional.

How Quickly Does Mounjaro Lower Blood Sugar? (Unofficial)

First Week

Modest improvements in fasting glucose (1 to 2 mmol/L reduction) as the medication starts working.

4 to 12 Weeks

Most dramatic improvements as doses increase. UK protocol starts at 2.5mg for four weeks, then increases every four weeks (5mg, 7.5mg, 10mg, 12.5mg, up to 15mg).

12 to 24 Weeks

Maximum HbA1c reduction achieved on optimised maintenance dose.

Long-term

Blood sugar stabilises at optimal levels once you’ve been on a consistent dose for three to six months.

The gradual dose escalation minimises side effects. It allows your body to adapt, so don’t expect immediate dramatic changes.

Does Mounjaro Cause Low Blood Sugar (Hypoglycaemia) if Your Blood Sugar Isn’t High?

• Used alone or with metformin: Very low risk (below 2% in trials). Mounjaro’s glucose-dependent mechanism only triggers insulin release when blood sugar is elevated.
• Combined with sulphonylureas or insulin: Risk increases to 15% to 20% without dose adjustments. Your healthcare provider will typically reduce these medications to prevent hypoglycaemia.
• In non-diabetics: Uncommon but possible, especially at higher doses. Blood sugar may drop to 3.5 to 4 mmol/L, causing shakiness or fatigue.

Patients experiencing symptoms of low blood sugar should contact their diabetes care team promptly. Medication adjustments should only be made under professional supervision. Contact your diabetes care team to discuss medication adjustments. Never alter Mounjaro dosing independently.

Mounjaro for Blood Sugar vs Weight Loss

Mounjaro’s primary MHRA-approved indication is glycaemic control in type 2 diabetes, not weight loss. Whilst substantial weight loss occurs (averaging 15% to 22% of body weight over 72 weeks), this is a beneficial secondary outcome supporting improved insulin sensitivity rather than the medication’s principal purpose. If you’re interested in Mounjaro specifically for weight loss, find out how our Mounjaro weight loss service works.

For people with type 2 diabetes, addressing both hyperglycaemia and excess weight creates synergistic benefits. Weight loss improves insulin sensitivity, reduces pancreatic strain, and lowers cardiovascular risk. 

However, NHS and private prescribers focus on HbA1c targets and reducing diabetes complications. Expecting Mounjaro solely for cosmetic weight loss represents off-label use that most NHS clinicians won’t support.

Who May Benefit Most From Mounjaro?

Best suited for:

• Adults with type 2 diabetes not achieving HbA1c targets on first-line treatments (metformin, sulphonylureas, SGLT2 inhibitors)
• Patients with significant insulin resistance and excess weight
• Those experiencing weight gain on insulin or hypoglycaemia on sulphonylureas

Not suitable for:

• Type 1 diabetes (requires insulin replacement)
• Personal or family history of medullary thyroid carcinoma or MEN syndrome type 2
• Severe gastrointestinal disease, gastroparesis, or previous pancreatitis
• Pregnancy or breastfeeding (discontinue two months before conception)

Older adults and people with kidney or liver impairment can generally use Mounjaro with appropriate monitoring.

Common Blood Sugar-Related Side Effects

• Nausea: Affects 20% to 30% of users, typically during the first few weeks or after dose increases. Usually resolves within two to four weeks.
• Appetite suppression: Can lead to inadvertent under-eating, potentially causing lower-than-usual glucose readings, especially if taking other diabetes medications.
• Temporary glucose variability: During dose escalation, expect wider day-to-day swings. Stabilises within four to eight weeks on consistent dosing.
• Dehydration: Secondary to gastrointestinal symptoms can affect meter accuracy. Maintain adequate hydration throughout treatment.

Contact your GP if gastrointestinal symptoms persist beyond one month. You develop dehydration signs (dark urine, dizziness), or glucose readings become erratic without explanation.

NHS & MHRA Guidance on Mounjaro

The MHRA licensed Mounjaro in September 2022, confirming it meets UK standards for quality, safety, and efficacy. However, NHS availability depends on NICE cost-effectiveness assessments, which continue to evolve.

NHS access: Requires prior authorisation and specific eligibility criteria (inadequate response to two or more oral medications, minimum HbA1c thresholds, BMI requirements). Often limited to specialist diabetes services with potential waiting times of several months.

Private prescribing: Available through private clinics following a comprehensive medical assessment. Costs typically range from £150 to £250 monthly, depending on dose. Patients bear full medication costs but avoid NHS waiting times and restrictions.

Frequently Asked Questions

Does Mounjaro lower blood sugar immediately? 

No. Modest reductions appear within 24 to 72 hours, but full effects develop over 12 to 24 weeks as doses increase.

Can Mounjaro replace insulin?

Sometimes. Some patients reduce or eliminate insulin requirements, but this depends on diabetes duration, beta-cell function, and individual response. Your diabetes team will determine if insulin reduction is safe.

Is Mounjaro better than Ozempic for blood sugar? 

Yes, by approximately 0.5% greater HbA1c reduction in head-to-head trials, likely due to its dual GIP and GLP-1 action.

Does Mounjaro work if you’re not overweight? 

Yes. Core glucose-lowering mechanisms work independently of baseline weight, though lean individuals may need closer monitoring.

Can non-diabetics experience blood sugar drops? 

Mild drops to 3.5 to 4.5 mmol/L are possible, occasionally causing symptoms. True hypoglycaemia is uncommon but possible at higher doses.

Does Mounjaro 2.5mg lower blood sugar? 

Yes, though 2.5mg is the starting dose with modest effects. Maximum glucose-lowering occurs at higher maintenance doses (10mg to 15mg).

How to avoid low blood sugar on Mounjaro? 

Maintain regular meal timing, reduce sulphonylureas or insulin if combining medications. Monitor glucose regularly during dose adjustments, and avoid prolonged fasting.

Does Mounjaro lower blood sugar too much? 

Rarely used alone. Risk increases when combined with insulin or sulphonylureas without dose adjustments. Your healthcare team will titrate medications appropriately.

Final Thoughts

Mounjaro lowers blood sugar in type 2 diabetes via dual GLP-1 and GIP action. Its glucose-dependent effect means a low risk of hypoglycaemia when used alone. Though caution is needed alongside insulin or sulphonylureas.

For UK patients with poor diabetes control, Mounjaro offers strong glycaemic improvement and weight loss. NHS access is currently limited pending NICE guidance, while private prescriptions cost around £150–£250 per month.

Speak with your GP or diabetes specialist to decide whether Mounjaro is suitable for your treatment plan.